$CLOV $CEMI $NURO it’s worth adding next low float 🚀 to your list $CMMB! 1) Niche pharmaceutical market worth over $3 billion for anti-fibrotic and anti-inflammatory disorders (Trading less than $200 million market cap) 2) Low Float! Almost all the big runners lately are low float stocks! MRIN CARV TPST SGOC NURO CEMI 3) Working with a known drug receptor (rare to know this early) & has both EU and USA Orphan Drug Designation...gives high likelihood of approval (accelerated approval) with multiple exclusivity perks! 4) Main drug CM-101 is an Antibody monoclonal therapeutic! Novel way of reprogramming the body....futuristic medicine! *FDA recently approved 100th monoclonal antibody therapeutic 5) ALL of their previous studies were HIGHLY successful and very optimistic!
1
4
4 Likes